CYBB/NOX2 in conventional DCs controls T cell encephalitogenicity during neuroinflammation

ABSTRACT

Whereas central nervous system (CNS) homeostasis is highly dependent on tissue surveillance by immune cells, dysregulated entry of leukocytes during autoimmune neuroinflammation causes severe immunopathology and neurological deficits. To invade the CNS parenchyma, encephalitogenic T helper (T_H) cells must encounter their cognate antigen(s) presented by local major histocompatibility complex (MHC) class II-expressing antigen-presenting cells (APCs). The precise mechanisms by which CNS-associated APCs facilitate autoimmune T cell reactivation remain largely unknown. We previously showed that mice with conditional deletion of the gene encoding the essential autophagy protein ATG5 in dendritic cells (DCs) are resistant to EAE development. Here, we report that the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 2, also known as CYBB/NOX2, in conventional DCs (cDCs) regulates endocytosed MOG (myelin oligodendrocyte protein) antigen processing and supports MOG-antigen presentation to CD4⁺ T cells through LC3-associated phagocytosis (LAP). Genetic ablation of Cybb in cDCs is sufficient to restrain encephalitogenic T_H cell recruitment into the CNS and to ameliorate clinical disease development upon the adoptive transfer of MOG-specific CD4⁺ T cells. These data indicate that CYBB-regulated MOG-antigen processing and LAP in cDCs licenses encephalitogenic T_H cells to initiate and sustain autoimmune neuroinflammation.

Abbreviations: Ag: antigen; APC: antigen-presenting cell; AT: adoptive transfer; ATG/Atg: autophagy-related; BAMs: border-associated macrophages; BMDC: bone marrow-derived DC; CD: cluster of differentiation; CNS: central nervous system; CSF2/GM-CSF: colony stimulating factor 2 (granulocyte-macrophage); CYBB/NOX2/gp91^phox: cytochrome b-245, beta polypeptide; DC: dendritic cell; EAE: experimental autoimmune encephalomyelitis; fl: floxed; FOXP3: forkhead box P3; GFP: green fluorescent protein; H2-Ab: histocompatibility 2, class II antigen A, beta 1; IFN: interferon; IL: interleukin; ITGAX/CD11c: integrin subunit alpha X; LAP: LC3-associated phagocytosis; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; MFI: median fluorescence intensity; MG: microglia; MHCII: major histocompatibility complex class II; MOG: myelin oligodendrocyte glycoprotein; MS: multiple sclerosis; NADPH: nicotinamide adenine dinucleotide phosphate; ODC: oligodendroglial cell; OVA: ovalbumin; pDC: plasmacytoid DC; Ptd-L-Ser: phosphatidylserine; PTPRC: protein tyrosine phosphatase, receptor type, C; ROS: reactive oxygen species; SLE: systemic lupus erythematosus; T_H cells: T helper cells; TLR: toll-like receptor; ZBTB46: zinc finger and BTB domain containing 46

Introduction

Surveillance of the central nervous system (CNS) by immune cells maintains tissue homeostasis and facilitates the elimination of infectious pathogens. During immune-mediated demyelinating conditions, such as multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE), however, auto-aggressive T helper (T_H) cells gain access to the CNS parenchyma, where they induce an inflammatory cascade, leading to demyelination, axonal loss, and brain atrophy [1]. Before they can breach the glia limitans and infiltrate the parenchyma, myelin-specific T_H cells require reactivation by CNS-associated major histocompatibility complex (MHC) class II (MHCII)-expressing antigen-presenting cells (APCs), which have sampled myelin protein from oligodendrocytes [2–5]. Recent studies employing conditional deletion of MHCII molecules in CNS-associated APC subsets indicated that conventional DCs (cDCs), in contrast to microglial cells and macrophages positioned at CNS interfaces, are essential for reactivating encephalitogenic T_H cells and disease development [4–6]. The mechanisms by which APCs license T cells to initiate neuroinflammation are, however, poorly understood.

The phagocyte NADPH oxidases belong to the NOX family of reactive oxygen species (ROS)-generating multiprotein complexes, known for their bactericidal activity within neutrophils and macrophages in a process termed respiratory burst. Central components of the NADPH oxidase multiprotein complex are the X-chromosomal-encoded CYBB/NOX2 and CYBA/p22^phox, which form a stable, but inactive, membrane-bound heterodimer during steady-state. Upon activation, the heterodimer and the cytosolic regulatory subunits of the NADPH oxidase complex (NCF4/p40^phox, NCF1/p47^phox, NCF2/p67^phox) translocate to the forming phagosome at the plasma membrane and aid in the complex assembly with the small GTPase RAC1, which is required to fully trigger the ROS-generating activity of the complex [7]. In MS lesions, components of the NADPH oxidase complex (CYBB/NOX2, CYBA/p22^phox, NCF1/p47^phox) are upregulated and coexpressed in CNS resident and infiltrating myeloid cells, predominantly localized in areas of initial tissue damage and at perivascular sites in proximity to T cells [8]. While excessive extracellular ROS provision has been linked with inflammation-induced tissue injury and neurodegeneration [9–11], recent studies indicated that intracellular generation of ROS by the NADPH oxidase complex restrains the inflammatory propensity of myeloid cells through LC3-associated phagocytosis (LAP), triggered by receptor-mediated uptake of extracellular particles [12–14ssss]. Mice that lack LAP components, such as CYBB/NOX2, in their macrophages spontaneously develop a proinflammatory systemic lupus erythematosus (SLE)-like phenotype [13]. In contrast, in vitro studies reported that LAP in myeloid cells can support CD4⁺ T cell responses by promoting sustained MHCII antigen presentation [15,16] and we recently demonstrated that DC-specific deletion of Atg5 (autophagy-related 5), essential for both canonical autophagy and LAP, confers resistance to EAE development induced by MOG-specific T cells [6]. Here, we sought to determine the role of DC-intrinsic CYBB/NOX2 as an essential LAP component for encephalitogenic T cell reactivation and CNS tissue injury during EAE.

Results

Deleting Cybb in cDCs confers protection to adoptive transfer EAE

To investigate the impact of CYBB/NOX2 in DCs during EAE development, we generated ITGAX/CD11c-specific conditional knockout mice for Cybb (Cybb^flox/flox × Itgax-Cre-GFP, designated cybb^fl/fl-Itgax-Cre). Assessing the targeting specificity of this strain revealed a complete reduction of CYBB in conventional DCs (cDCs), whereas LY6C1^hi, LY6C1^lo monocytes, and B cells continued to express CYBB (Figure 1A and S1A). Steady-state frequencies of splenic DC subsets remained unchanged in cybb^fl/fl-Itgax-Cre mice as compared to littermates (Cybb^fl/fl) (Fig. S1B). Cybb-deficient cDCs did not differ from their Cybb-competent counterparts in surface expression levels of MHCII and costimulatory molecules (Fig. S1 C-E) and produced similar levels of IL12B/IL12 p40 upon CD40 ligation (Fig. S2A). Within isolated MHCII-expressing CNS-associated leukocytes, Cre-GFP was strongly expressed in both cDC1 and cDC2 subsets but only to a minor extent in border-associated macrophages (BAMs). Plasmacytoid DCs (pDCs), immature and mature B cells, as well as microglia, were GFP-negative and did not, therefore, express Cre recombinase (Figure 1B). Frequencies and absolute numbers of CNS-associated APCs and expression levels of MHCII, as well as costimulatory molecules, were similar in cybb^fl/fl-Itgax-Cre mice as compared to Cre^– littermates (Figure 1B).

Figure 1.

Cre recombinase efficiently targets conventional DCs in cybb^fl/fl-Itgax-Cre animals. (A) Representative histograms depicting Cre-GFP expression of either ITGAX^hi MHCII^hi splenic DCs (cDCs), LY6C1^hi ITGAM⁺ monocytes (LY6C1^hi Monos), LY6C1^lo ITGAM⁺ monocytes (LY6C1^lo Monos) or CD19⁺ MHCII⁺ B cells in Cybb^fl/fl (gray) or cybb^fl/fl-Itgax-Cre (red) mice in steady-state (upper panel). Quantification of Cre-GFP median fluorescence intensity (MFI) in splenic leukocyte subsets. Each data point represents one individual animal (middle panel). Western blot analysis for protein expression of CYBB in the respective cellular compartments is shown. ACTB served as a loading control (lower panel). Statistical analysis: Unpaired two-tailed Student t-test was applied. Mean ± SEM is depicted. ns, not significant: P > 0.05; ***P < 0.001. (B) Quantification of MFI for Cre-GFP, MHCII, CD80, and CD86 in CNS-resident immune cell subsets. Each data point represents one individual animal. One representative out of 3 experiments is shown. Statistical analysis: Unpaired two-tailed Student t-test was applied. Mean ± SEM is depicted. ns, not significant: P > 0.05; *P < 0.05; ***P < 0.001. cDC, conventional dendritic cells; BAMS, border-associated macrophages; iB cells, immature B cells

Adoptive transfer of T cell receptor-transgenic MOG_35-55-specific CD4⁺ T cells resulted in a strongly reduced disease severity and incidence of EAE in cybb^fl/fl-Itgax-Cre mice as compared to Cybb^fl/fl control littermates (Figure 2A). Like in the steady-state, CYBB expression was efficiently targeted in cybb^fl/fl-Itgax-Cre mice during the disease state as quantified in CNS-derived ITGAX^hi MHCII^hi myeloid cells at day 20 post-transfer (p.t.) of myelin-specific T cells (Figure 2B). Similar to our findings in atg5^fl/fl-Itgax-Cre mice [6], cybb^fl/fl-Itgax-Cre mice did not significantly differ from their Cybb^fl/fl counterparts in incidence rates and clinical severity grades upon active EAE induction with an emulsion of MOG_35-55 peptide in complete Freund´s adjuvant (CFA, s.c.) together with intraperitoneal (i.p.) injections of pertussis toxin (Figure 2C).

Figure 2.

CYBB in cDCs controls CNS immune invasion of primed myelin-specific CD4⁺ T cells. (A) EAE was induced via adoptively transferring 2D2/TCR^MOG-derived encephalitogenic CD4⁺ T cells into Cybb^fl/fl (gray triangles) or cybb^fl/fl-Itgax-Cre (red circles). Each data point represents the mean of 6 (Cybb^fl/fl) and 6 (cybb^fl/fl-Itgax-Cre) animals respectively (left). Change of body weight (middle) and quantification of disease incidence is depicted (right). One representative out of 3 experiments is shown. (B) EAE was induced via adoptively transferring 2D2/TCR^MOG-derived encephalitogenic CD4⁺ T cells into Cybb^fl/fl (gray triangles) or cybb^fl/fl-Itgax-Cre (red circles). On day 20 after the transfer, animals were sacrificed and CNS was analyzed via flow cytometry for CYBB expression in myeloid cells. Statistical analysis: Mean ± SEM is depicted. Two-way ANOVA (left). Gating strategy for flow cytometry analysis in the CNS of Cybb^fl/fl or cybb^fl/fl-Itgax-Cre animals. Representative density plots are depicted (middle). Quantified median fluorescence intensity (MFI) of intracellular CYBB protein expression in ITGAX^hi MHCII^hi CNS cells on day 20 post-transfer (Right). Statistical analysis: Mean ± SEM is depicted. Unpaired two-tailed Student t-test was applied. ns, not significant: P > 0.05; *P < 0.05; ***P < 0.001. (C) EAE was induced via active immunization with MOG_35–55 peptide in Cybb^fl/fl (gray triangles) cybb^fl/fl-Itgax-Cre (red circles) mice. Each data point represents the mean of 9 (Cybb^fl/fl) and 10 (cybb^fl/fl-Itgax-Cre) animals, respectively (left). Change of body weight (middle) and quantification of disease incidence is depicted (right). Pooled data of 2 independent experiments are shown. (D) EAE was induced via adoptively transferring 2D2/TCR^MOG-derived encephalitogenic CD4⁺ T cells into Cybb^fl/fl (gray triangles) or cybb^fl/fl-Zbtb46-Cre (purple circles). Each data point represents the mean of 8 (Cybb^fl/fl) and 7 (cybb^fl/fl-Zbtb46-Cre) animals respectively (left). Change of body weight (middle) and quantification of disease incidence is depicted (right). Pooled data of 2 independent experiments are shown. Statistical analysis: Mean ± SEM is depicted. Two-way ANOVA was applied

Although cDCs are the only ITGAX-expressing MHCII⁺ APCs in the steady-state brain [5], other cells, including monocytes, microglia, and BAMs can upregulate ITGAX upon activation [17]. To determine whether the protective effect of Cybb ablation following adoptive transfer of myelin-specific T cells is specifically mediated by cDCs, we next crossed the Cybb^fl/fl strain to Zbtb46-Cre (also known as zDC-Cre) mice wherein Cre expression and Cybb deletion is directed by the promoter of the transcription factor Zbtb46 (zinc finger and BTB domain containing 46). Zbtb46 is expressed in pre-DCs and their progeny, but not in monocytes, macrophages, and other myeloid cells, and, therefore, allows for delineating ITGAX⁺ lineages [18–20]. Similar to cybb^fl/fl-Itgax-Cre mice, the adoptive transfer of myelin-specific T cells resulted in reduced disease severities and incidence of EAE in Cybb^fl/fl-Zbtb46-Cre mice as compared to Cybb^fl/fl control littermates (Figure 2D and S2B). Thus, the genetic ablation of Cybb in cDCs confers protection to EAE development induced by primed, myelin-specific T_H cells.

Cybb expression in DCs regulates myelin-specific CD4⁺ T cell invasion of the CNS parenchyma

Histological analysis of the lumbar spinal cord sections derived from cybb^fl/fl-Itgax-Cre mice, examined at day 28 after T cell transfer, showed substantially reduced immune invasion of the CNS with significantly lower numbers of T cells and LAMP2⁺ myeloid cells (Figure 3A,B). Furthermore, CNS tissue injury as reflected by demyelination and axonal damage was greatly reduced in these mice (Figure 3A,B). Immunofluorescence microscopy analysis revealed increased numbers of CD4⁺ MKI67⁺ T cells in the tissue from Cybb^fl/fl mice indicating in vivo proliferation of encephalitogenic T_H cells. In contrast, CD4⁺ MKI67⁺ T cells were rarely detectable in cybb^fl/fl-Itgax-Cre mice (Figure 3C).

Figure 3.

Reduced immune cell infiltration, demyelination, and axonal damage in the CNS of cybb^fl/fl-Itgax-Cre animals upon adoptive transfer EAE. (A) Histology of lumbar spinal cord sections from Cybb^fl/fl and cybb^fl/fl-Itgax-Cre animals on day 28 upon adoptive transfer of encephalitogenic CD4⁺ T cells using hematoxylin and eosin staining (HE), staining with antibodies against CD3E for T lymphocytes, against LAMP2 for myeloid cells, against PTPRC for B cells, against amyloid precursor protein for APP deposits and luxol fast blue (LFB-PAS) for demyelination. Scale bars: 200 µm (insert 50 µm) (left). (B) Quantification of cells or deposits per mm² and fraction of demyelination is depicted (right). (C) Immunofluorescence microscopy analysis of CD4⁺ MKI67⁺ cells. Scale bars: 20 µm. Each data point represents one individual animal (Cybb^fl/fl: gray triangles; cybb^fl/fl-Itgax-Cre: red circles). Statistical analysis: Unpaired two-tailed Student t test was applied. Mean ± SEM is depicted. ns, not significant: P > 0.05; *P < 0.05; **P < 0.005

During steady-state, we did not detect any differences in frequencies of splenic CD4⁺ T cells, CD8A⁺ T cells, CD4⁺ FOXP3⁺ regulatory T cells, and B cells in cybb^fl/fl-Itgax-Cre mice as compared to littermates (Figure 4A and S3). Furthermore, the production of inflammatory cytokines (IFNG, CSF2/GM-CSF, and IL17A) upon activation was unchanged in cybb^fl/fl-Itgax-Cre-derived CD4⁺ and CD8A⁺ T cells (Figure 4B).

Figure 4.

CYBB deficiency in ITGAX⁺ cDCs limits the accumulation of myelin-reactive CD4⁺ T cells within the CNS. (A) Representative density plots depicting splenic CD8A⁺ and CD4⁺ T cell subsets in Cybb^fl/fl and cybb^fl/fl-Itgax-Cre animals at steady-state (upper panels). Frequencies of splenic T cells (CD3⁺ of PTPRC⁺) and T cell subsets (CD8A⁺, CD4⁺ of CD3E⁺ and FOXP3⁺ IL2RA⁺ TREGs of CD4⁺ CD3E⁺) in Cybb^fl/fl (gray triangles) cybb^fl/fl-Itgax-Cre (red circles) mice at steady-state (lower panels). Each data point represents one individual animal. Pooled data of 2 independent experiments is shown. Statistical analysis: Unpaired two-tailed Student t-test was applied. Mean ± SEM is depicted. ns, not significant: P > 0.05. (B) Frequencies of Cybb^fl/fl- (gray triangles) and cybb^fl/fl-Itgax-Cre-derived (red circles) proinflammatory cytokine (IFNG [left], CSF2/GM-CSF [middle], and IL17A [right]) producing splenic CD4⁺ (upper) and CD8A⁺ (lower) T cells were analyzed via intracellular cytokine staining upon stimulation with PMA/ionomycin (PMA/Iono). Each dot represents an individual animal. Pooled data of 2 independent experiments is shown. med; medium control. (C) PTPRC^a congenic 2D2/TCR^MOG mice were adoptively transferred into either PTPRC^b congenic Cybb^fl/fl (gray) or PTPRC^b congenic cybb^fl/fl-Itgax-Cre (red) mice to induce passive EAE. (D) Representative contour plots depicting relative fractions of PTPRC^a+ and PTPRC^b+ cells in the CNS (upper) and relative fractions of CD4⁺ and CD8A⁺ cells among PTPRC^a+ cells (lower). (E) Quantified CNS frequencies of CD4⁺ PTPRC^a+ and CD8A⁺ PTPRC^a+ cells among live single cells in Cybb^fl/fl (gray triangles) and cybb^fl/fl-Itgax-Cre (red circles) mice upon adoptive transfer EAE. Each data point represents an individual animal. Experiment was terminated after the first animal reached day 3 post-onset. Statistical analysis: Unpaired two-tailed Student t-test was applied. Mean ± SEM is depicted. ns, not significant: P > 0.05; **P < 0.005. Quantified CNS frequencies of proinflammatory cytokine-producing PTPRC^a+ CD4⁺ T cells among live single cells (F) upon ex vivo antigen challenge. Quantified CNS (G, H) and spleen (I) frequencies of cytokine-producing cells among CD4⁺ T cells upon ex vivo antigen challenge. Each data point represents an individual animal. Statistical analysis: Unpaired two-tailed Student t-test was applied. Mean ± SEM is depicted. ns, not significant: P > 0.05; *P < 0.05; **P < 0.005. O, OVA_323–339 peptide; M, MOG_35–55 peptide

To further study frequencies and effector functions of CNS-infiltrating T cells during EAE, mice were sacrificed on day 18 post-transfer (p.t.) of PTPRC^a/CD45.1⁺ myelin-specific CD4⁺ T cells into PTPRC^b/CD45.2⁺ recipients, i.e., day 3 after disease onset in control littermates (Figure 4C). In line with the histological data, cybb^fl/fl-Itgax-Cre mice showed substantially reduced accumulation of adoptively transferred PTPRC^a+ encephalitogenic T_H cells within the CNS (Figure 4 D,E). Although the overall frequency of cytokine-expressing cells was reduced (Figure 4F), the ability of CNS-invading PTPRC^a+ T_H cells to produce proinflammatory cytokines (IFNG, CSF2, and IL17A) upon ex vivo restimulation with their nominal antigen was preserved in cybb^fl/fl-Itgax-Cre recipients indicated by the unchanged frequency of cytokine-expressing cells within the PTPRC^a+ CD4⁺ compartment (Figure 4G). Not adoptively transferred PTPRC^b+ T cells derived from the CNS of recipient mice (Figure 4H) and splenic CD4⁺ T cells (Figure 4I) did not show any cytokine expression upon ex vivo restimulation with MOG_35-55 peptide. These data indicate that lack of CYBB function in DCs does not impair effector functions of primed, CNS-infiltrating T_H cells, but restrains their in situ reactivation and accumulation.

Absence of Cybb in cDCs abrogates LC3-associated phagocytosis and myelin antigen presentation to CD4⁺ T cells

The finding that Cybb expression in cDCs limits autoimmune CD4⁺ T cell accumulation within the CNS during EAE suggested a role of CYBB in antigen processing and presentation. In macrophages, CYBB recruitment to early phagosomes is essential for LAP, which requires some, but not all, components of the autophagy machinery to conjugate the autophagy protein LC3 directly to phagosomal membranes upon phagocytosis [12]. In contrast to canonical autophagy, LAP degrades extracellular material that engages receptor signaling after apoptotic cell recognition through phosphatidylserine (Ptd-L-Ser)-recognizing receptors or engaged by particles containing pathogen-associated molecular patterns [12].

To determine whether Cybb-deficiency impairs phagocytosis, execution of LAP, and myelin antigen presentation in cDCs, we first assessed the phagocytic capacity and LC3-conjugation to phagosomes in ITGAX⁺ bone marrow-derived DCs (BMDCs) upon loading with polystyrene beads or LAP-triggering TLR2-CLEC7A-agonistic zymosan particles. The expression of CYBB was efficiently ablated in cybb^fl/fl-Itgax-Cre-derived BMDCs (Figure 5A,B). Both, cybb^fl/fl-Itgax-Cre- and Cybb^fl/fl-derived BMDCs phagocytosed similar numbers of either naked polystyrene beads or zymosan particles, as quantified by laser scanning confocal microscopy (Figure 5 C,D). Conjugation of LC3 to lipids in the phagosomal membrane, however, was absent in cybb KO BMDCs (Figure 5 E,F), indicating that Cybb-deficient DCs, similar to macrophages [12], are unable to execute LAP.

Figure 5.

Absence of CYBB in cDCs abrogates LC3-associated phagocytosis. (A) Immunofluorescence confocal laser scanning microscopy of BMDCs (FACS-purified for ITGAX⁺ MHCII⁺) either derived from Cybb^fl/fl or cybb^fl/fl-Itgax-Cre animals and stained for CYBB. Scale bar 10 µm. (B) Western blot analysis for protein expression of CYBB in Cybb^fl/fl- and cybb^fl/fl-Itgax-Cre-derived BMDCs (FACS-purified for ITGAX⁺ MHCII⁺) is shown. ACTB served as a loading control. (C, D) Quantification of BMDC fraction that phagocytosed zymosan particles or inert beads (left) and the number of zymosan- or inert bead-containing vesicles per BMDC over time (right). (E) Immunofluorescence confocal laser scanning microscopy of BMDCs that had phagocytosed zymosan particles visualizing CYBB (red), LC3 (green) and DAPI (blue). Representative pictures are depicted. Original magnification with 63×, 1.4 N.A. oil immersion lens. (F) Quantification of recruitment of CYBB and LC3 to zymosan-containing vesicles over time. Mean ± SEM is depicted

We next analyzed whether the absence of CYBB in cDCs impairs their T cell stimulatory capacity. To this end, purified DC-Cybb^–/– or DC-Cybb^+/+ primary splenic DCs were first loaded with MOG_35-55 peptide or MOG_1-125 protein and cocultured with MOG_35–55–specific CD4⁺ T cells. Lack of Cybb in cDCs did not affect activation of 2D2 cells, as measured by the production of IFNG and IL17A or proliferation of MOG-specific T cells (Figure 6A-C). Since LAP requires triggering through receptor-mediated antigen uptake, such as Ptd-L-Ser-recognizing receptors, we next investigated whether uptake of damaged Ptd-L-Ser-exposing oligodendroglial cells (ODCs) by cDCs triggers MOG-specific T cell activation in a CYBB-dependent manner (Figure 6D and S4). Irradiated Ptd-L-Ser^hi compared with non-irradiated Ptd-L-Ser^lo MOG-expressing ODCs were loaded onto DC-Cybb^–/–- or DC-Cybb^+/+-derived primary splenic DCs.

Figure 6.

CYBB-deficiency in cDCs limits endogenous myelin peptide presentation following phagocytosis of injured oligodendroglial cells. (A) Representative histograms depicting proliferation of 2D2/TCR^MOG-derived myelin-specific CD4⁺ T cells upon coculture with MOG_35-55-pulsed FACS-purified ITGAX^hi MHCII^hi splenic DCs (Cybb^fl/fl: gray; cybb^fl/fl-Itgax-Cre: red). 2D2/TCR^MOG-derived CD4⁺ T cells alone served as a control (light gray). Quantification of 2D2/TCR^MOG-derived CD4⁺ T cell proliferation (CellTrace Violet^dim) (B) or IFNG and IL17 secretion (C) upon coculture with either MOG_35-55- (M_35-55) or MOG_1-125 (M_1-125)-pulsed FACS-purified ITGAX^hi MHCII^hi splenic DCs. One representative of 2 independent experiments is shown. Statistical analysis: Mean ± SEM is depicted. Unpaired two-tailed Student t-test was applied. ns, not significant: P > 0.05. (D) Set-up for sequential coculture assay using damaged (UV-irradiated) or untreated MOG-expressing oligodendroglial cell line MO3.13 (MOG⁺ ODCs). (E) Surface expression levels of CD80, CD86, CD40 and MHCII on ITGAX^hi MHCII^hi are similar upon coculture with iODCs when comparing Cybb^fl/fl and cybb^fl/fl-Itgax-Cre genotypes. Quantification of IFNG and IL17 secretion (F) or 2D2/TCR^MOG-derived CD4⁺ T cell proliferation (CellTrace Violet^dim) (G, left panel) upon coculture with FACS-purified ITGAX^hi MHCII^hi splenic DCs previously pulsed with either UV-irradiated (iODC) or untreated (ODC) MOG-expressing oligodendroglial cells. One representative of 2 independent experiments is shown. Statistical analysis: Mean ± SEM is depicted. Unpaired two-tailed Student t-test was applied. *P < 0.05; **P < 0.005. (G, right panel) Representative histograms depicting proliferation of 2D2/TCR^MOG-derived myelin-specific CD4⁺ T cells upon sequential coculture with ODC-pulsed FACS-purified ITGAX^hi MHCII^hi splenic DCs (Cybb^fl/fl: gray; cybb^fl/fl-Itgax-Cre: red). 2D2/TCR^MOG-derived CD4⁺ T cells alone served as a control (light gray)

The surface expression of CD80, CD86, CD40, and MHCII on ITGAX^hi MHCII^hi DCs was similar upon coculture with Ptd-L-Ser^hi ODCs (Figure 6E). Endogenous myelin-derived peptide presentation was assessed by IFNG and IL17A production and proliferation of cocultured MOG_35–55–specific CD4⁺ T cells. Both cytokine production and proliferation were significantly enhanced in CD4⁺ T cells cocultured with Ptd-L-Ser^hi ODC-loaded cDCs, as compared to those loaded with Ptd-L-Ser^lo ODCs (Figure 6 F,G, and S4). Increased CD4⁺ T cell activation upon the presentation of endogenous myelin antigen derived from Ptd-L-Ser^hi ODCs was, however, abrogated in Cybb-deficient cDCs (Figure 6F,G). These data indicate that CYBB is required for LAP and MHCII antigen presentation in cDCs upon receptor-mediated phagocytosis.

Discussion

Encephalitogenic T_H cells require the re-encounter of their cognate antigen presented by CNS-associated APCs to initiate autoimmune tissue damage. Although the EAE model has been successfully used for decades to study T cell-mediated CNS autoimmunity, the origin and nature of APCs, which reactivate pathogenic T cells, have been heavily disputed and the mechanisms by which they permit T cell invasion and CNS injury are largely unknown. Our study demonstrates that CYBB in cDCs enhances myelin-specific CD4⁺ T cell activation through antigen presentation and permits CNS immune invasion and facilitates T_H-cell mediated tissue damage during AT-EAE.

The CNS parenchyma and interfaces host heterogeneous populations of constitutively and optionally MHCII-expressing myeloid and lymphoid cells, including subsets of microglial cells, border-associated macrophages, monocyte-derived cells, conventional DCs (cDCs), plasmacytoid DCs, and B cells [21]. Recent studies employing conditional deletion of MHCII molecules in CNS-associated APC subsets [5] and with lineage-specific depletion of APCs [22], identified cDCs among ITGAX⁺ cells as the main facilitators of early T cell entry into the CNS during adoptive transfer EAE (AT-EAE), the prototypical tool to study T cell–APC interactions during neuroinflammation in vivo. EAE can also be induced by s.c. immunization with myelin antigen and CFA, i.e., active EAE, which requires ITGAX^neg LY6C1^hi CCR2 (C-C chemokine receptor type 2)⁺ monocytes, precursors of CNS-invading monocyte-derived DCs, but not ITGAX⁺ cDCs for clinical disease development [3,23–26]. We did not observe significant differences in incidence rates and clinical severity grades in cybb^fl/fl-Itgax-Cre mice or atg5^fl/fl-Itgax-Cre mice [6] following active EAE induction. Lack of Cre-mediated recombination in ITGAX^neg LY6C1⁺ monocytes, and a delayed targeting of Cybb or Atg5 in CNS-invading monocyte-derived DCs in cybb^fl/fl-Itgax-Cre and atg5^fl/fl-Itgax-Cre mice [6] might have contributed to this effect.

CYBB-mediated ROS production can be detected in many hematopoietic and non-hematopoietic cell lineages, such as fibroblasts, endothelial cells, and cardiomyocytes [27], and mice globally deficient in CYBB-expression are reported to be partially protected from EAE development after active immunization [28]. Here, we specifically determined CYBB function in DCs. The protective effect of CYBB deficiency was stronger in cybb^fl/fl-Itgax-Cre mice as compared to Cybb^fl/fl-Zbtb46-Cre mice. Although cDCs isolated from the unperturbed brain are superior to other potential APCs in their ability to present myelin antigen from the steady-state CNS and inducing proliferation of myelin-specific CD4⁺ T cells [5,22], ablation of ITGAX⁺ cells in ITGAX^DTR mice confers resistance to AT-EAE, while lack of cDCs in ZBTB46^DTR (also known as zDC^DTR) mice reduced the susceptibility to AT-EAE only by half [22]. These data, along with our observations, indicate that ITGAX⁺ APCs, other than cDCs, might additionally contribute to EAE development and progression.

The reduced proliferative capacity and accumulation of adoptively transferred encephalitogenic T cells in cybb^fl/fl-Itgax-Cre mice prompted us to investigate the function of CYBB in antigen presentation. In contrast to neutrophils and macrophages, phagocytosis and phagosomal ROS production by DCs serve other purposes than the mere clearance of microbes or cell debris. Their phagosomes contain extracellular antigenic material ready to be processed and presented to T cells. Efficient and prolonged presentation of peptide antigens in DCs is supported by limiting endophagocytic proteolysis through low expression levels and low recruitment of proteolytic enzymes to phagosomes [29,30], limited acidification by the V-ATPase [31], and active alkalinization of the endosomal and phagosomal lumen by NADPH oxidase complex-generated superoxide, which consumes protons produced by the V-ATPase proteases and was shown to support cross-presentation by CD8A⁺ DCs [32,33]. The low amount of proteolysis observed in APCs expressing high amounts of MHCII, such as cDCs, as opposed to macrophages, is thought to render these cells particularly susceptible to pH modulation and very efficient in recovering immunogenic peptides and assembling peptide-MHCII complexes [29]. Prolonged conservation of antigenic peptides in APCs has previously been attributed to LC3⁺ phagosomes whose formation requires NADPH oxidase complex-generated ROS during the non-canonical autophagy pathway termed LC3-associated phagocytosis (LAP) [12,13,15,34]. LC3 lipidation to single-membrane compartments in the endo-lysosomal system following endocytic engulfment events also occurs during micropinocytosis [35,36], entosis [35,37], and LC3-associated endocytosis (LANDO) [38]. LANDO in microglia has recently been shown to facilitate beta-amyloid clearance in murine models of Alzheimer disease and mice lacking LANDO but not canonical autophagy in microglia have a robust increase in proinflammatory cytokine production associated with accelerated neurodegeneration [38]. While LANDO requires the expression of ATG5 and RUBCN, it remains to be clarified whether the generation of ROS by the NADPH oxidase complex is as essential for LANDO as it is for LAP. Within the myeloid cell compartment, LAP has primarily been studied in macrophages. We observed that LAP, as defined by LC3 conjugation to TLR-engaged phagosomes, is also abrogated in CYBB-deficient DCs. Functional consequences of LAP deficiency in macrophages and DCs in vivo, however, appear to be fundamentally different.

Mice that lack LAP components such as Atg5, Atg7, BECN1/Beclin1 in their macrophages, as conditionally ablated using lysozyme M (LysM)-Cre-lox recombination or globally deficient in CYBB function, develop an auto-inflammatory phenotype with aging, that can be accelerated by chronic exposure to apoptotic cells [13]. These mice depict impaired clearance of dying cells, resulting in a systemic proinflammatory syndrome with elevated serum inflammatory cytokines, generation of autoantibodies, glomerular immune complex deposition, and evidence of kidney damage, commonly associated with SLE [13]. Using a similar approach with LysM-Cre-mediated ablation of gene products essential for LAP but not canonical autophagy, Cunha et al. recently demonstrated that disruption of LAP but not canonical autophagy limits tumor growth by tumor-associated macrophages upon phagocytosis of dying tumor cells associated with enhanced proinflammatory gene expression and type I interferon responses [14]. These studies suggest that LAP executed by macrophages is a mediator of immunosuppression and facilitates immune-silent clearance of dying cells. We [6] and others [39] previously demonstrated that DC-specific deletion of Atg5 or Atg7, required for both LAP and canonical autophagy, results in the resistance to or amelioration of EAE development induced by myelin-specific CD4⁺ T cells through limiting antigen presentation. Canonical autophagy delivers intracellular antigens for MHCII presentation, while EAE development is driven by an antigen not intrinsically expressed by professional APCs and, therefore, requires endocytosis, followed by myelin antigen processing and presentation. The finding that DC-specific deletion of CYBB and ATG5 function inhibits LC3 recruitment to phagosomes, antigen presentation to encephalitogenic CD4⁺ T cells, CNS immune invasion, and clinical disease development, indicates that LAP rather than canonical autophagy in DCs augments T cell immunopathology in EAE. In line with our findings, in vitro studies demonstrate that LAP in myeloid cells can support CD4⁺ T cell responses by promoting sustained MHCII antigen presentation [15,16]. Thus, while inefficient clearance of dying cells through LAP in macrophages results in exacerbated autoinflammation, impairment of LAP in DCs dampens CD4⁺ T cell-mediated autoimmunity by limiting sustained antigen presentation.

Autopsy brains from patients with MS exhibit upregulation and coexpression of NADPH oxidase complex components such as CYBB, CYBA, and NCF1 in CNS resident and infiltrating myeloid cells predominantly localized in areas of initial tissue damage and at perivascular sites in proximity to T cells [8]. While ROS production by activated microglia and macrophages contribute to neuronal injury during CNS inflammation [8,9,40–42], conditional gene targeting approaches consistently demonstrated that MHCII expression in microglia is dispensable for EAE development [4,5,43]. Our study indicates that ROS production by cDCs augments T cell-mediated tissue injury through antigen presentation and supports the concept that pharmacological modulation of endogenous redox regulation by CYBB and restraining LAP-mediated antigen presentation should be explored for its potential therapeutic merit in MS.

Materials and methods

Mice

Wild type C57BL/6 mice were purchased from Janvier Labs. Congenic C57BL/6- PTPRC^a/CD45.1 mice were purchased from Charles River Laboratories. The generation and characterization of Cybb^flox/flox mice were reported previously [44]. Tg(Itgax-cre,-EGFP)4097Ach mice (designated Itgax-Cre), B6.Cg-Zbtb46^{tm3.1(cre)Mnz}/J mice (designated Zbtb46-Cre, also known as zDC-Cre) and MOG-specific TCR transgenic mice C57BL/6-Tg(Tcra2D2, Tcrb2D2)1Kuch/J (designated 2D2/TCR^MOG) were purchased from the Jackson Laboratory. 2D2/TCR^MOG mice were backcrossed to PTPRC^a/CD45.1 congenic C57BL/6 mice in our facility. All animals were bred and housed in the University of Zurich and University of Münster animal facilities in individually ventilated cages on a 12 h light/dark cycle with food and water available ad libitum according to institutional guidelines, as well as Swiss and German animal laws. Itgax-Cre and Zbtb46-Cre mice were crossed with Cybb^flox/flox mice in order to obtain Cybb^flox/flox × Itgax-Cre and Cybb^flox/flox × Zbtb46-Cre mice respectively (designated cybb^fl/fl-Itgax-Cre and cybb^fl/fl-Zbtb46-Cre) on a C57BL/6 background. Cybb^flox/flox mice (designated Cybb^fl/fl) were used as littermate controls. All animal protocols were approved by and conducted in accordance with the cantonal veterinary office of the canton of Zurich, Switzerland (ZH192/17) and the State Agency for Nature, Environment and Consumer Protection North Rhine-Westphalia, Germany (81–02.04.2018.A383).

Genotyping

Itgax-Cre, Zbtb46-Cre, and Cybb^flox/flox mouse genotypes were determined via PCR analysis on DNA from tail or ear biopsies by the use of the following primer pairs (5ʹ-3ʹ): Itgax-Cre: GCG GTC TGG CAG TAA AAA CTA TC (transgene forward), GTG AAA CAG CAT TGC TGT CAC TT (transgene reverse), CTA GGC CAC AGA ATT GAA AGA TCT (internal positive control forward), GTA GGT GGA AAT TCT AGC ATC ATC C (internal positive control reverse); Zbtb46-Cre: GCG CTG GAG TTT CAA TAC C (mutant reverse), GTA AGC ATA GCC CTG CTC CT (common), CTG GTT GAG GAT GAG GAT GA (wild type forward); Cybb^flox/flox: GTA AAT TCA CTG TTC TGG GTC (forward), ACA TGT TCT TCT CAC AGG CTC (reverse).

2D2/TCR^MOG transgenic mice were genotyped via flow cytometry, as previously described [6].

Induction of EAE

AT-EAE was induced as previously described [6]. In brief, 2D2/TCR^MOG mice were immunized with 200 μg of MOG_35–55 (MEVGWYRSPFSRVVHLYRNGK; Genscript, RP10245) emulsified in CFA (BD Difco, 263810) and treated with 200 ng of pertussis toxin (List Biological Laboratories, 179B) i.p. on the day of immunization. After 7 d, splenocytes and lymph node cells were cultured in complete RPMI (10% heat-inactivated FCS, 1% penicillin-streptomycin [P-S], and 50 µM beta-mercaptoethanol) containing MOG_35–55 (10 μg/ml) and recombinant IL23A (10 ng/ml; eBioscience, 14-8231-63) for 48 h. To induce EAE, we (i.p.) injected 10 × 10⁶ cells into recipient mice, which had been sublethally irradiated with 550 rad (Rad Source Technologies, Type RS 2000) 1 d prior to cell transfer. Active EAE was induced, as described above, but included a second treatment with 200 ng of pertussis toxin on day 2. Clinical manifestations of EAE and weight loss were monitored and documented daily. Mice were scored as follows: 0 = no detectable signs of EAE, 0.5 = distal limp tail, 1 = complete limp tail, 1.5 = limp tail and hindlimb weakness, 2 = unilateral partial hindlimb paralysis, 2.5 = bilateral partial hindlimb paralysis, 3 = complete bilateral hindlimb paralysis, 3.5 = complete bilateral hindlimb paralysis and partial forelimb paralysis, 4 = moribund (animal unable to move due to tetraparalysis), 5 = animal found dead. The last documented score of euthanized or dead animals was carried forward for statistical analysis.

Generation of BMDCs

Bone marrow-derived DCs (BMDCs) were generated, as previously described [6]. Briefly, bone marrow cells were cultured with BMDC culture medium (10% inactivated FCS [Sigma, F2442-6X500 ML], 1% P-S [Life Technologies, 15070–063], 50 μM beta-mercaptoethanol [Thermo Fisher Scientific, 21985023], and 2.5 ng/ml recombinant mouse CSF2/GM-CSF [Biolegend, 576306] in RPMI-1640 [Life Technologies, 7001612]). A complete medium change was performed every 2nd day.

ODC phagocytosis and coculture assay

Coculture assays were carried out, as previously described [6]. ODC^MOG+ were either UVB irradiated (870 mJ/cm²) or left untreated. cybb^fl/fl-Itgax-Cre and Cybb^fl/fl-derived splenocytes were isolated, and the frequency of ITGAX⁺ MHCII⁺ DCs was determined via FACS using a small aliquot of the splenocyte suspension. Bulk splenocytes from cybb^fl/fl-Itgax-Cre and Cybb^fl/fl mice were cocultured (10:1 ratio of ODC^MOG+ to ITGAX⁺ MHCII⁺ DCs) overnight (37°C, 5% CO₂) in cell culture dishes with either Ptd-L-Ser^hi or Ptd-L-Ser^lo ODC^MOG+ in R10 medium supplemented with 1% P-S. The next day, ITGAX⁺ MHCII⁺ DCs were FACS-purified (BD FACSAria III 5 L) from all conditions (cybb^fl/fl-Itgax-Cre + Ptd-L-Ser^lo ODC^MOG+; cybb^fl/fl-Itgax-Cre + Ptd-L-Ser^hi ODC^MOG+; Cybb^fl/fl + Ptd-L-Ser^lo ODC^MOG+; Cybb^fl/fl + Ptd-L-Ser^hi ODC^MOG+). ITGAX⁺ MHCII⁺ DC fractions were further cocultured at 1:5 ratio (DC:T cell) in a 96-well U bottom plate (Sigma, CLS3360) overnight (37°C, 5% CO₂) with 2D2/TCR^MOG-derived MACS-purified CD4⁺ T cells (pre-stained with 5 µM CellTrace^TM Violet proliferation dye according to the manufacturer’s recommendation, [Thermo Fisher Scientific, C34557]) in a total volume of 200 µl of R10 supplemented with 1% P-S and IL2 (10 ng/ml; R&D Systems, 402-ML-100). Wells containing 2D2/TCR^MOG CD4⁺ T cells only or anti-CD3 and anti-CD28 antibodies (5 µg/ml each) were included. After 24 h of incubation, half of the cell culture supernatants were collected for analysis of IFNG concentrations by ELISA (eBioscience, 88-7314-76). Wells were replenished with additional medium, and on day 5, cells were collected and stained with a viability dye, fluorescently labeled anti-CD3, and anti-CD4 antibodies and analyzed for T cell proliferation.

Leukocyte isolation from the spleen

Tissue was dissected into small pieces and digested for 30 min at 37°C and 5% CO₂ with collagenase D (0.4 mg/ml; Sigma, 11088866001) and DNase (20 μg/ml; Qiagen, 79254) in PBS (Thermo Fisher Scientific, 10010023). The digested tissue was passed through a 70-μm cell strainer to obtain single-cell suspensions. Red blood cell lysis (2 min, RT) was performed using ACK lysis buffer (Thermo Fisher Scientific, A1049201). Cell concentration was determined, and samples were kept on ice until further processing.

Leukocyte isolation from CNS

CNS tissue was dissected into small pieces, suspended in digest buffer (collagenase D [0.2 mg/ml; Sigma, 11088866001] and DNase [20 μg/ml; Qiagen, 79254]), and incubated for 40 min at 37°C and 5% CO₂. The digested tissue was passed through a 70-μm nylon mesh. Pelleted cells were suspended in 30% Percoll (GE Healthcare, 17-0891-01) in PBS and ultracentrifuged (Sorvall RC6 Plus Superspeed Centrifuge; Thermo Fisher Scientific) for 30 min at 1590 × g at 4°C. Cell concentration was determined, and samples were kept on ice until further processing.

Confocal microscopy

In order to stain for LC3 and CYBB, BMDCs were FACS-purified sorting for ITGAX^hi MHCII^hi cells (BD FACSAria III 5 L) and plated in 8-well glass chamber slides (pre-coated with 1× poly-L-lysine [Sigma, P4832] in _ddH₂O) at a density of 1–2 × 10⁵. Cells were plated 1 d prior to phagocytosis of zymosan particles (Invivogen, TLRL-ZYN) or 2 μm latex beads (Sigma, L0280-1 ML) allowing cells to attach. Cells were incubated with either zymosan or 2 μm latex beads (Ratio 20 zymosan particles: 1 cell) for the indicated time points. Following the phagocytosis assay, cells were washed with PBS and fixed with 4% PFA (Sigma, 1004968350) for 15 min at RT in the dark. After fixation, cells were washed twice with PBS and transferred into a blocking solution (PBS, 1% FCS) for 1 h. After blocking, staining with primary antibodies was performed (LC3: 1:200; MBL International, PM036 and CYBB: 1:100; Santa Cruz Biotechnology, sc-130543) for 1 h at RT. Staining was followed by 2 washes with PBS and incubation with secondary antibodies (Alexa Fluor 488 or Alexa Fluor 555 anti-rabbit or anti-mouse: 1:500; Invitrogen, A11070, A11001) for 45 min at RT. After secondary staining, cells were washed in PBS twice for at least 5 min and counterstained with DAPI (1:5000; Thermo Fisher Scientific, D1306) for 5 min at RT. Three washing steps were performed with PBS for at least 10 min. Slides were mounted with mounting medium (DAKO, S302380-2), kept overnight at RT in the dark and were then transferred to 4°C for long-term storage. Pictures were acquired using a 63×, 1.4 N.A. oil immersion lens with an upright confocal laser scanning microscope (SP8-UV; Leica Microsystems). The acquisition of the data was performed using the LAS Leica Application Imaging software. Analysis of the picture was performed with the Fiji package on ImageJ Software (v1.50i; NIH).

Flow cytometry

Single-cell suspensions were pre-incubated with Fc receptor block (20 min, 4°C, 22.4 μg/ml; clone: 2.4 G2; Bio X Cell, CUS-HB-197) followed by staining with the LIVE/DEAD Fixable Aqua Dead Stain Kit (Thermo Fisher Scientific, L34957) in PBS at 4°C in the dark. Cells were stained with fluorochrome-labeled antibodies in FACS buffer (0.5% BSA [Sigma, 05470] and 0.01% NaN₃ [Sigma, S8032-25 G] in PBS) for 30 min at 4°C in the dark. Intracellular cytokines were determined upon ex vivo restimulation with either OVA_323–339 peptide (ISQAVHAAHAEINEAGR; InvivoGen, vac-isq), MOG_35–55 peptide (both 20 µg/ml), or phorbol 12-myristate 13-acetate (PMA)/ionomycin (PMA: 1:50000, Sigma, P1585; ionomycin: 1:747, Sigma, I3909) in R10 (10% FCS in RPMI-1640) supplemented with 1% P-S. Brefeldin A (10 μg/ml; Sigma, B5936-200UL) was added to block cytokine secretion. Samples were incubated in the restimulation medium at 37°C and 5% CO₂ for 4 h, and then washed twice in cold PBS followed by centrifugation at 400 × g and 4°C for 5 min. After surface staining, cells were resuspended in 200 μl of Cytofix/Cytoperm buffer (BD Biosciences, 554714) and incubated for 30 min at 4°C in the dark. Afterward, cells were stained with fluorochrome-labeled antibodies against the proinflammatory cytokines of interest. Samples were immediately recorded with the BD LSRFortessa using FACSDiva software v6.1.3 (BD Biosciences). Analysis was performed using the FlowJo software v9.3.1 (Tree Star).

Determination of cytokine concentration

IL12B, IFNG, and IL17A concentrations in cell culture supernatants were measured using the Mabtech mouse IL12B ELISA development kit (Mabtech, 3451–1 H-6), the mouse IFNG Uncoated ELISA kit (Thermo Fisher Scientific, 88–7314), and the mouse IL17A ELISA Kit (Thermo Fisher Scientific, BMS6001), respectively. All measurements were performed according to the respective manufacturer’s recommendation.

Magnetic activated cell sorting

All magnetic activated cell sorting (MACS) procedures were carried out using magnetic MicroBeads from Miltenyi (anti-ITGAX/CD11c, 130-097-059; anti-CD4, 130-049-201; anti-biotin, 120-000-900) and the autoMACS Pro Separator (Miltenyi, 130-092-545) and in accordance with the provider’s protocol recommendations.

Cell culture

Cells were treated in sterile biological safety hoods and cultured in incubators at 37°C, 5% CO₂ with the specific medium containing the appropriate nutritional and survival factors. MOG-overexpressing MO3.13 cells (oligodendroglial cells; ODC^MOG+) were cultured in DMEM (Thermo Fisher Scientific, 41965062) supplemented with 1% P-S and 10% FCS.

Histology

For the histological analysis, the spinal cord was dissected and fixed overnight in 4% PFA. The tissues were embedded in paraffin, and sequential sections were processed. The samples were stained with hematoxylin and eosin (HE; Abcam, ab245880), luxol fast blue (LFB-PAS; Sigma, L0294-500 ML) to determine the degree of demyelination, mouse anti-mouse APP (3 µg/ml; clone: 22 C11; Millipore, MAB348) for assessment of axonal damage, rat anti-mouse LAMP2 (2.5 µg/ml; clone: M3/84; BD Pharmigen, 550292) for macrophages/microglia, rat anti-mouse PTPRC/CD45 R/B220 (2.5 µg/ml; clone: RA3-6B2; BD Pharmigen, 561878;) for B cells, rat anti-human CD3E (3.5 µg/ml; mouse cross-reactivity; clone: CD3-12; Bio-Rad, MCA1477 T) for T cells. For APP, LAMP2, PTPRC, and CD3E immunohistochemical analysis, the primary antibodies were incubated overnight (4°C). Biotin-labeled secondary antibodies (2.5 µg/ml, Southern Biotech, 3050–08; 1031–08) were added for 45 min at RT, followed by incubation with streptavidin (Southern Biotech, 7100–05) for 45 min at RT. 3ʹ-diaminobenzidine (DAB) brown chromogen (Dako, K8000) was used for the resolution of the aforementioned antibodies.

For the analysis of T cell proliferation via MKI67, the tissues were stained with rabbit anti-mouse CD4 (1.4 µg/ml; clone: EPR19514; Abcam, ab183685) and rat anti-mouse MKI67 (5 µg/ml; clone: SolA15; eBioscience, 14-5698-82;) for 24 h at 4°C. The secondary antibodies donkey anti-rabbit Alexa Fluor 647 (4 µg/ml, Invitrogen, A31573) and donkey anti-rat Alexa Fluor 488 (4 µg/ml, Invitrogen, A21208) were incubated for 2 h at RT. Nuclei were counterstained with DAPI (Carl Roth, 6335.2).

SDS-PAGE and western blot

Protein quantification was performed, as previously described [6]. Protein samples were diluted with 4× Laemmli buffer (Bio-Rad, 11697498001) and boiled for 5 min at 95°C. 0.75-mm gels were run at 70 V and proteins were transferred onto a pre-activated polyvinylidenefluoride (PVDF) membrane (GE Healthcare, RPN303 F) via a semidry transfer system (Bio-Rad, 170–3940) at 10 V for 1 h. The membrane was blocked for 1 h at RT in blocking solution (4% skimmed milk [Sigma, 70166–500 G] and 0.1% Tween 20 [Sigma, 9005-64-5] in PBS) followed by incubation with primary antibody (anti-CYBB, 1:2000; BD, 611415; HRP-labeled anti-ACTB, 1:50000; Sigma, A3854) diluted in blocking solution overnight at 4°C on a shaker. After washing for at least 5 min with PBS-T (0.1% Tween 20 in PBS), the membrane was incubated for 1 h at RT with secondary antibody (HRP-labeled anti-mouse, 1:50000; Invitrogen, A10668) diluted in blocking solution on a shaker. Pierce ECL Western Blotting Substrate (Thermo Fisher Scientific, 32106) was used to develop the membrane. Protein bands were visualized with a Vilber Fusion FX detector. Application of the automated saturation option in the Fusion software (v17.1) allowed for the selection of unsaturated pictures.

Antibodies

BioLegend

Pacific Blue–conjugated anti-PTPRC^b/CD45.2 (clone: 104; 1:400; 109820), APC–conjugated anti-mouse H2-Ab1 (clone: M5/114.15.2; 1:800; 107614), Brilliant Violet 650–conjugated anti-CD86 (clone: GL-1; 1:200; 105035), PE-Cy7–conjugated anti-ITGAX/CD11c (clone: N418; 1:400; 117318), PE–conjugated anti-PTPRC^a/CD45.1 (clone: A.20; 1:200; 110707), PerCP-Cy5.5 – and biotin–conjugated anti-LY6C1 (clone: HK1.4; 1:200; 128012 and 128004), APC-Cy7–conjugated anti-ITGAM/CD11b (clone: M1/70; 1:200; 101226), Pacific Blue–conjugated anti-CD19 (clone: 6D5; 1:400; 115523), Brilliant Violet 785–conjugated anti-CD8A (clone: 53–6.7; 1:100; 100750), Alexa Fluor 700–conjugated anti-LY6G (clone: 1A8; 1:200; 127622), APC–conjugated anti-CD4 (clone: GK1.5; 1:200; 100412), Brilliant Violet 605–conjugated anti-IL2RA/CD25 (clone: PC61; 1:200; 102036), FITC–conjugated anti-IFNG (clone: XMG1.2; 1:400, 505806), PE-Cy7–conjugated anti-IL17A (clone: TC11/18H10; 1:200, 506922), PE-Cy–conjugated anti-CD40 (clone: 3/23; 1:50; 124622), unconjugated IgG2a, kappa isotype control antibody (clone: MOPC-173; 15 µg/ml, 400202).

eBioscience

Alexa Fluor 700–conjugated anti-CD19 (clone: eBio1D3; 1:200;56-0193-82), Alexa Fluor 700–conjugated anti-CD4 (clone: GK1.5; 1:200; 56-0041-82), PE–conjugated anti-SIGLECH (clone: eBio440 c; 1:800; 12-0333-82), PerCP-Cy5.5–conjugated anti-FOXP3 (clone: FJK-16 s; 1:100; 45-5773-82).

BD Biosciences

APC-Cy7–conjugated anti-PTPRC/CD45 (clone: 30-F11; 1:400; 557659), PE-CF594–conjugated anti-CD8A (clone: 53–6.7; 1:400; 562283), PE–conjugated anti-CSF2/GM-CSF, (clone: MP1-22E9; 1:250, 55440), Unconjugated anti-CD3E (clone: 145-2C11; 5 μg/ml; 553058), unconjugated anti-CD28 (clone: 37.51; 5 μg/ml; 553295).

Others

anti-CYBB (1:2000; clone: 53; BD, 611415 and 1:100; clone: 54.1; Santa Cruz, sc-130543 PE), HRP-labeled anti-ACTB (1:50000; Sigma, A3854) unconjugated anti-LC3 (1:200; MBL, PM036), HRP–conjugated goat anti-mouse IgG (1:10000; Bio-Rad, 172-1011-MSDS), HRP–conjugated ACTB (1:50000; clone: 13G11; Biomol, 137402.100), unconjugated anti-CD40 (15 µg/ml; clone: FGK4.5/FGK45; Bio X Cell, BE0016 – 2), unconjugated anti-FCGR3/CD16 and FCGR2B/CD32 (22.4 μg/ml; clone: 2.4G2; Bio X Cell, CUS-HB-197), anti-MOG (clone: 8-18C5 [6],).

Statistical analysis

Statistical tests applied are indicated in the respective figure legends. Unpaired, two-tailed student t-test and two-way ANOVA were performed. A P-value < 0.05 was considered statistically significant. The asterisks depicted in the figures translate into the following grouping: *P < 0.05, **P < 0.01, ***P < 0.001. All quantitative analyses were performed with GraphPad Prism v5.0a for Mac OSX (GraphPad Software, Inc).

Funding Statement

This work was supported by the Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung [31003A_169664].

Disclosure statement

The authors have declared that no conflict of interest exists.

Supplementary material

Supplemental data for this article can be accessed here.